Hematopoiesis is a tightly regulated biological process that relies upon complicated interactions between blood cells and their microenvironment to preserve the homeostatic balance of long-term hematopoietic stem cells (LT-HSCs), short-term HSCs (ST-HSCs), multipotent progenitors (MPPs), and differentiated cells. Adhesion molecules like P-selectin (encoded by the Selp gene) are essential to hematopoiesis, and their dysregulation has been linked to leukemogenesis. Like HSCs, leukemic stem cells (LSCs) depend upon their microenvironments for survival and propagation. P-selectin plays a crucial role in Philadelphia chromosome -positive (Ph + ) chronic myeloid leukemia (CML). In this paper, we show that cells deficient in Pselectin expression can repopulate the marrow more efficiently than wild type controls. This results from an increase in HSC self-renewal rather than alternative possibilities like increased homing velocity or cell cycle defects. We also show that Pselectin expression on LT-HSCs, but not ST-HSCs and MPPs, increases with aging. In the absence of P-selectin expression, mice at 6 months of age possess increased levels of short-term HSCs and multipotent progenitors. By 11 months of age, there is a shift towards increased levels of long-term HSCs. Recipients of BCR-ABL-transduced bone marrow cells from Pselectin-deficient donors develop a more aggressive CML, with increased percentages of LSCs and progenitors. Taken together, our data reveal that P-selectin expression on HSCs and LSCs has important functional ramifications for both hematopoiesis and leukemogenesis, which is most likely attributable to an intrinsic effect on stem cell self-renewal.
Introduction
Hematopoietic stem cells (HSCs) rely upon exquisite interactions with each other and their microenvironments to fulfill their specific cellular functions. HSCs are responsible for the maintenance of the blood cell pool and can fulfill this function because of their unique capacities to self-renew and to differentiate into functioning blood cells. Proper hematopoietic homeostasis is essential in order to preserve the appropriate balance of longterm HSCs (LT-HSCs), short-term HSCs (ST-HSCs), and multipotent progenitors (MPPs). To achieve this, HSCs must be regulated and maintained through assorted growth factors, cell cycle regulation, transcription factors, epigenetic modulation, and interactions with the microenvironment [1, 2] .
P-selectin is a well-studied adhesion protein known to be expressed on the surface of activated endothelial cells and platelets [3] . We have previously shown that P-selectin plays a crucial role in Philadelphia chromosome -positive (Ph + ) chronic myeloid leukemia (CML) [4] . The mechanism by which the lack of Pselectin was thought to promote the rate of CML appeared to involve the capacity of these leukemic cells to be retained in the bone marrow through adhesive interactions with the stroma. This defect had been thought to be related to the stroma and not to the leukemic stem cell (LSC) itself. Here, we investigate the role of Pselectin plays on HSC-and LSC-containing lin low/Sca-1 + /c-kit + (LSK) cells. We demonstrate that the loss of P-selectin expression leads to an increased capacity to repopulate the bone marrow in both the short-and long-term. We show that this is likely due to an enhanced capacity for self-renewal. We also demonstrate with our retroviral transduction/transplantation BCR-ABL-induced CML mouse model that the loss of P-selectin expression on LSCcontaining LSK cells significantly increased the severity of the disease. We show that aging mice exhibit elevated levels of Pselectin on the surfaces of their LT-HSCs (CD34 2 LSK) but not their ST-HSCs and MPPs (CD34 + LSK).
Materials and Methods

Mouse strains
Wild type C57BL/6J mice (WT hereafter), transgenic WT mice ubiquitously expressing eGFP (C57BL/6-Tg [UBC-GFP] 30Scha/J ; UBC-GFP hereafter), congenic WT mice expressing CD45.1 (B6.SJL-Ptprc a Pepc b / BoyJ ; CD45.1 hereafter), and WT mice with homozygous null mutations in the gene encoding the P-selectin protein (B6.129S7-Selp tm1Bay ; Selp 2/2 hereafter) were obtained from The Jackson Laboratory (Bar Harbor, ME) and maintained in accordance with the standards set forth by the institution's Animal Care and Use Committee.
Bone marrow transduction and transplantation
As previously described, the cDNA encoding the p210 isoform of BCR-ABL was subcloned into the retroviral MSCV-IRES-eGFP (MIG) in order to make the bicistronic MIG-p210 plasmid construct [4, 5, 6] . Helper-free, ecotropic retroviral stocks of MIG and MIG-p210 were generated by transient transfection of 293T/17 cells with the respective constructs. Viral titers were determined by analyzing the percentage of GFP + cells following infection of NIH3T3 cells with serial dilutions of retroviral stock.
A CML-like myeloproliferative disease can be induced following transplantation of bone marrow cells derived from 5-fluorouracil (5-FU)-pretreated donor mice, pre-stimulated with IL3, IL6, and stem cell factor (SCF), and transduced with retrovirus encoding BCR-ABL (MIG-p210) [5] . As previously described, 12-week-old female donor mice (Selp 2/2 or WT) were pretreated with 5-FU (200 mg/kg) via lateral tail vein injection [4, 5, 6] . Four days post-injection, donor mice were sacrificed, and bone marrow cells were harvested. Cells were pre-stimulated with IL3, IL6, and SCF and subjected to two rounds of cosedimentation/infection with high-titer MIG-p210 retroviral stock. Cells were collected and transplanted into irradiated (2 rounds of 550 cGy) WT mice (2610 5 cells/mouse). Twelve-weekold female WT recipient mice were closely monitored for outward signs of CML-like disease. For the assay designed to test the role of aging on leukemogenesis, we used 15-month-old Selp 2/2 and WT male mice for donors and transplanted 2.0610 5 cells into each irradiated 3-month-old WT male recipient. Hematopoietic tissues and peripheral blood were collected from sick mice at specific time points in order to characterize the onset and development of disease. For the whole bone marrow repopulation study, we transduced 5-FU pretreated bone marrow cells derived from 12 week old female Selp 2/2 and WT mice and pre-stimulated with IL3, IL6, and SCF. These cells were then subjected to two rounds of retroviral infection with a construct encoding GFP (MIG) and transplanted via lateral tail vein injection into irradiated (2 rounds of 550 cGy) 12 week-old female WT mice (2610 5 cells/mouse).
Bone marrow transduction efficiency assay
As previously described, 12-week-old female donor mice (Selp
or WT) were pre-treated with 5-FU (200 mg/kg) via lateral tail vein injection [4, 5, 6] . Four days post-injection, donor mice were sacrificed, and bone marrow cells were harvested. Cells were prestimulated with IL3, IL6, and SCF and subjected to two rounds of co-sedimentation/infection with high-titer MIG-p210 retroviral stock. The virus-transduced bone marrow cells were cultured for 48 h. Then, those bone marrow cells were analyzed to determine the percentage of GFP 
In vitro culture of LSCs
Bone marrow cells were isolated from CML mice and were cultured in vitro in the presence of StemSpan SFEM (Stem Cell Technologies, Vancouver, CA), stem cell factor, insulin-like growth factor-2, thrombopoietin, heparin, and fibroblast growth factor, as described previously [7, 8] .
Cell cycle analysis of HSCs
Cell cycle status was assessed by staining cells with 5 uM Hoechst blue for 90 minutes. The percentage of HSCs in S+G2M stage was determined by FACS [9] .
Flow cytometry
The percentages of LT-HSCs, LT-LSCs (both CD34 2 LSK), ST-HSCs+MPPs, ST-LSCs+MPPs (both CD34 + LSK), as well myeloid progenitor cells (non-leukemic and leukemic), were determined by flow cytometry following the isolation of bone marrow cells of mice that had been transplanted with cells derived from Selp 2/2 and WT donors. Animals were sacrificed at 14 d post-transplant (in the case of the MIG-p210 transplant) or 18 d post-transplant (in the case of the MIG repopulation transplant) in order to observe changes in these blood cell populations and the disease developed. Prior to analysis, bone marrow cells were incubated in an NH 4 Cl red blood cell lysis buffer (pH 7.4) to facilitate the removal of erythrocytes. Single cells were analyzed for viability by propidium iodide staining. Viable cells were deemed transduced by MIG or MIG-p210 retrovirus if they expressed GFP. In cells transduced by the MIG-p210, cells expressing GFP were deemed leukemic, as this was an indication that BCR-ABL was simultaneously being expressed from the same bicistronic construct. Viable GFP + cells were stained with Lin, Sca1, c-Kit (CD117), CD34, and CD16/ 32 in order to determine the percentages of stem cells and progenitors attributable to the donor transplantation of cells. Antibody to P-selectin was purchased from eBioscience (San Diego, CA). 
Bone marrow competition assay
Results
Loss of Selp expression supports bone marrow repopulation
We previously showed a role for P-selectin in our mouse model for human CML. In that study, we demonstrated that Selp 2/2 recipients of Selp 2/2 donor cells developed CML more quickly than WT recipients of WT donor cells. In this study, we wanted to better understand the role P-selectin plays on donor cell function, irrespective of the recipient stromal contribution, during normal hematopoiesis and during Ph + leukemogenesis in mice. We infected bone marrow cells derived from 5-FU-treated donor WT and Selp 
Loss of Selp expression supports HSC long term engraftment
We sought to characterize the underlying mechanism that enabled Selp 2/2 bone marrow cells to more efficiently repopulate the bone marrow space than WT cells. Using a competitive repopulation assay to test long-term engraftment (Figure 2A) (Fig. 2E ). LSK cells from Selp 2/2 or WT mice were normalized and injected into recipient mice. At 3 h posttransplant, animals were sacrificed and the numbers of HSCcontaining LSK cells were counted. Selp 2/2 recipients possessed modestly lower levels of LSK cells than WT recipients. Although these data are not statistically significant, the results are consistent with the competitive bone marrow homing assay, which suggest a decreased homing velocity.
We next wanted to determine whether Selp 2/2 mice exhibited changes in HSC quiescence (Fig. 2F) . Bone marrow cells isolated from Selp 2/2 and WT mice exhibited no changes in HSC quiescence, as measured by the percentage of LSK cells in the S + G2/M stages of the cell cycle. P-selectin expression exhibits an age-independent increase in expression on LT-HSCs P-selectin expression increases on the surface of HSCs with age [1] . We sorted LT-HSCs (CD34 2 LSK) and ST-HSCs + MPPs (CD34 + LSK) from the bone marrow of 2 month-old, 6 monthold, and 15 month-old WT mice to determine whether the increase was restricted to either HSC subpopulation. No changes were noted between 2 month-old and 6 month-old mice; however, P-selectin expression on the surface of LT-HSCs was increased in 15 month-old mice. Expression on ST-HSCs + MPPs remained unchanged (Fig. 3A) . These findings correlated with previous microarray and qRT-PCR data [2] .
Loss of P-selectin expression alters stem, progenitor, and mature cell fates in an age-dependent manner Selp 2/2 and WT mice were aged for 6, 8, 9, 10, and 11 months. We collected bone marrow cells from these mice at each of these time points for FACS analysis of HSC-containing LSK cells and progenitor populations (Fig. 3B) . We observed similar total numbers of bone marrow cells at 6, 8, 9, and 10 months of age, while there was a higher total of bone marrow cells in Selp 2/2 mice at 11 months of age when compared to the WT control. Overall, loss of Selp expression appeared to increase the total numbers of HSC-containing LSK cells in mice at 6 months of age, but this effect diminished with age. This finding corresponded with the levels of ST-HSC + MPPs that were observed. In contrast, there were increased levels of LT-HSCs (CD34 2 LSK) in the Selp 2/2 mice when compared to controls at most time points, except at 9 months. At 11 months, there was a significant increase in the levels of LT-HSCs present. There were significantly more CMPs in Selp 2/2 than in WT mice at 6 and 8 months, but this difference dissipated by 9 months. While it had no effect on GMP populations, loss of Selp expression caused a marked expansion the MEP populations at each time point tested. We observed an increasing number of Gr1 + cells present in the bone marrow, with a significant difference noted at 11 months. This corresponded to Gr1 + levels that were observed in the peripheral blood. While no significant differences were observed in the numbers of total leukocytes present in the peripheral blood until 11 months, there was a marked increase in the Gr1 + cells in the peripheral blood by 9 months that remained through 10 and 11 months. These findings were indicative of strain-and age-dependent effects on stem, progenitor, and mature myeloid cell populations.
Loss of Selp enhances the function of leukemia stem cells
Because loss of Selp expression enhances HSC function (Figure 1,2) , we examined whether Selp also regulates the function of leukemia stem cells (LSCs) using a BCR-ABL-induced CML as a disease model. CML is a stem cell disease, and we have previously identified LSCs for CML in mice [10] . We have previously shown that loss of Selp causes acceleration of CML development [4] , but it is unknown whether this is caused by a Pselectin-mediated effect resulting from its expression on the surface of LSCs. Bone marrow cells from 5-FU-treated donor WT and Selp 2/2 mice were infected with retrovirus expressing BCR-ABL-GFP. Irradiated WT recipients were transplanted with 2610 5 of these transduced donor cells. At 14 d post-transplant, recipient mice from each of the groups were sacrificed, and bone marrow cells were harvested and analyzed by FACS (Fig. 4) (Fig. 5B ).
Discussion
In a previous study, we showed that Selp 2/2 recipients of Selp 2/2 donor bone marrow transduced by BCR-ABL developed a more aggressive form of CML-like disease than the recipients of WT cells [4] . We demonstrated that in the absence of P-selectin expression in both donor cells and recipient stroma, BCR-ABL-expressing progenitors are prematurely released from the bone marrow due to an apparent adhesion defect; and this leads to significant pulmonary hemorrhages and cellular masses due to massive infiltration of myeloid leukemia cells. P-selectin expression has been associated with platelets and endothelial cells [3] and is known to contribute to variety of processes including coagulation, inflammation, and tumor metastasis [11, 12] . The traditional view was that stromal, P-selectin-expressing endothelial cells interact with Pselectin ligand-bearing (PSGL1) leukocytes and facilitate an assortment of processes including adhesion and rolling and cellular activation [13] . In addition, platelets expressing P-selectin are capable of binding directly to leukocytes, contributing to rolling, and to tumor cells, supporting metastasis [12] . Recent findings that HSCs express P-selectin [14] and the finding that the level of Pselectin expression on LT-HSCs increases with age (Ref. [2] and Figure 3A ) confound the current understanding of its role in mediating the leukocyte-stroma interaction [1, 14] and may have important implications for leukemogenesis [2] . This study addressed (Fig. 1) . In addition, significant differences in progenitor populations were noted. These differences were celldependent, as Selp 2/2 cells were not more susceptible to viral transduction than WT cells. Furthermore, we cultured of Selp Figure 2B ). This competitive advantage at the stem cell level led to the increased number of Selp 2/2 cells present in the peripheral circulation ( Fig. 2A) , as well as in the bone marrow space (Fig. 2B) . We attributed the advantage Selp 2/2 cells possess over WT cells to an enhanced capacity for self-renewal (Fig. 2C) . We observed that this functional advantage was not attributable to an enhanced homing velocity, as WT cells homed more efficiently than Selp 2/2 ( Figure 2D-E) . These findings are surprising in that we had previously shown through an alternative method that Selp 2/2 and WT cells homed with similar efficiencies when introduced into recipients of the same genetic background [4] . In this paper, the approach differed and relied upon a CD45.1 recipient. Thus, effects from different microenvironments (Selp 2/2 vs. WT) on donor cell homing could be avoided. This enabled us to focus our homing assay on the donor cells and not the recipient stroma. Our findings indicate an initial competitive disadvantage for Selp 2/2 donor cells because of a presumed inability to be retained in the bone marrow space. We speculate that the premature release of Selp 2/2 cells from the bone marrow may result in a compensatory increase in levels of Selp 2/2 cells. Alternatively, it is possible that other adhesion mechanisms may predominate in spite of Selp expression or at least may compensate for loss of function when Selp is not expressed. In the long term, Selp 2/2 cells possess a competitive advantage due to enhanced stem cell self-renewal properties.
We have previously shown that BCR-ABL-transformed HSCs exhibiting the LSK expression profile function as de facto CML stem cells [10] . In this paper, we demonstrate that in the absence of P-selectin expression on LSCs, a more aggressive form of CML develops, as indicated by the elevated percentage of LSCs observed in the bone marrow (Fig. 4) and the decline in mean survival time following transplantation of leukemic cells (Fig. 5) . The aggression with which CML proceeds is dependent on the donor LSC/progenitor. In fact, both LT-LSC (CD34 2 LSK) and ST-LSC + MPP (CD34 + LSK) percentages were increased in the bone marrow, and, as a result, the total number of leukemic cells in peripheral blood was increased. The increase in the percentage of LSCs is mostly attributable to the cell-intrinsic differences related to the expression of P-selectin. It has been speculated that LT-HSCs, when transformed, may actually be the true stem cell source for most myeloid leukemias [2] . With aging, there is an increase in LT-HSCs (Fig. 3) ; however, unlike LT-HSCs found in younger people, aged LT-HSC are often homeostatically disrupted [15] , and exhibit increasing levels of self-renewal and an unusual propensity to generate more myeloid than lymphoid progenitors [2] . This disruption in the lymphoid/myeloid balance, coupled with the overall elevation in LT-HSCs, contributes to making Ph + CML more common with age (according to NCI SEER 2001-2005, median age of diagnosis in the U.S. = 66 yrs. old; .50% of incidences diagnosed $65 yrs. old). We have shown in HSC-containing LSK cells that loss of Selp expression increased the capacity for their self-renewal (Fig. 2) . In the context of CML, we postulate that the loss of Selp expression increases LSC selfrenewal, thereby accelerating leukemogenesis. In older mice, loss of Selp expression may have additive or synergistic effects on leukemia development.
